Table 3 Adverse events potentially related to anticoagulation
Total N = 1174 | Intermediate anticoagulation N = 775 | Standard anticoagulation N = 399 | Crude difference (95%CI) | p value | |
|---|---|---|---|---|---|
Bleeding, n (%) | 95 (8) | 61 (8) | 34 (8) | -0.6 (-4.0 to 2.7) | 0.57 |
Gastro-intestinal tract, n (%) | 36 (4) | 25 (3) | 11 (3) | 0.5 (-1.6 to 2.5) | 0.66 |
Intracranial, n (%) | 10 (1) | 5 (1) | 5 (1) | -0.6 (-1.8 to 0.6) | 0.32 |
Deep haematoma, n (%) | 8 (1) | 7 (1) | 1 (0.25) | 0.7 (-0.2 to 1.5) | 0.28 |
Blood transfusion*, n (%) | 163 (14) | 98 (12.7) | 65 (16.3) | -3.7 (-8.0 to 0.6) | 0.08 |